Use of strong opioids for chronic pain in osteoarthritis: an insight into the Latin American reality

References

• Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115–2126.
   PubMed Web of Science ®Google Scholar
• Hinton R, Moody R, Davis AW. Osteoarthritis: diagnosis and therapeutic considerations. Am Fam Physician. 2002;65:841–848.
   PubMed Web of Science ®Google Scholar
• Lopez J, Burant CJ, Siminoff L, et al. Patient perceptions of access to care and referrals to specialists: a comparison of African-American and white older patients with knee and hip osteoarthritis. J Natl Med Assoc. 2005;97:667–673.
   PubMed Web of Science ®Google Scholar
• Wilkman A, Wardle J, Steptoe A. Quality of life and affective well-being in middle-aged and older people with chronic medical illness: a cross-sectional population based study. Plos One. 2011;6:1–9.
   Web of Science ®Google Scholar
• Maetzel A, Li L, Pencharz J, et al. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis. 2004;63(4):395–401.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2163–2196.
   PubMed Web of Science ®Google Scholar
• Peña Ayala AH, Fernández-López JC. Prevalencia y factores de riesgo de la osteoarthritis. Prevalence and risk factors of osteoarthritis. Rheumatol Clin. 2007;3(3):S6–S12.
   Google Scholar
• Comas M, Sala M, Román R, et al. Impact of the distinct diagnostic criteria used in population-based studies on estimation of the prevalence of knee osteoarthritis. Gac Sanit. 2010;24(1):28–32.
   PubMed Web of Science ®Google Scholar
• Allen KD, Golightly YM. Epidemiology of osteoarthritis: state of the evidence. Curr Opin Rheumatol. 2015;27(3):276–283.
   PubMed Web of Science ®Google Scholar
• Pereira D, Peleteiro B, Araújo J, et al. The effect of osteoarthritis on prevalence and incident estimates: a systematic review. Osteoarthritis Cartilage. 2011;19:1270–1285.
   PubMed Web of Science ®Google Scholar
• Community Oriented Program for the Control of Rheumatic Disease (COPCORD). [cited 2017 Jul 16]. http://www.copcord.org/publications
   Google Scholar
• Reginato AM, Riera H, Vera M, et al. Osteoarthritis in Latin America. Study of demographic and clinical characteristics in 3040 patients. J Clin Rheumatol. 2015;21:391–397.
   PubMed Web of Science ®Google Scholar
• Dunlop DD, Manheim LM, Song J, et al. Arthritis prevalence and activity limitations in older adults. Arthritis Rheum. 2001;44:212–221.
   PubMed Web of Science ®Google Scholar
• Hawker GA, Stewart L, French MR, et al. Understanding the pain experience in hip and knee osteoarthritis-an OARSI/OMERACT initiative. Osteoarthritis Cartilage. 2008;16:415–422.
   PubMed Web of Science ®Google Scholar
• Wilkie R, Peat G, Thomas E, et al. Factors associated with restricted mobility outside the home in community-dwelling adults ages fifty tears and older with knee pain: an example of use of the International Classification of Functioning to investigate participation restriction. Arthritis Rheum. 2007;57:1381–1389.
   PubMed Web of Science ®Google Scholar
• Hawker GA. Experiencing painful osteoarthritis: what have we learned from listening? Curr Opin Rheumatol. 2009;21:507–512.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014;10:437–441.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 disease and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2013;380:2197–2223.
   Web of Science ®Google Scholar
• Nüesch E, Dieppe P, Reichenbach S, et al. All cause and disease specific mortality in patients with hip or knee osteoarthritis: population based cohort study. BMJ. 2011;342:d1165.
   PubMed Web of Science ®Google Scholar
• Losina E, Walensky RP, Reichmann WM, et al. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med. 2011;154:217–226.
   PubMed Web of Science ®Google Scholar
• March LM, Bachmeier CJ. Economics of osteoarthritis: a global perspective. Baillieres Clin Rheum. 1997;11:817–834.
   PubMed Web of Science ®Google Scholar
• Leadini G, Salaffi R, Caporali B, et al. Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol. 2004;22:699–706.
   PubMed Web of Science ®Google Scholar
• Loza E, Lopez-Gomez JM, Abasolo L, et al. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum. 2009;61:158–165.
   PubMed Web of Science ®Google Scholar
• Le PC, Reygrobellet C, Gerentes I. Financial cost of osteoarthritis in France. The COART France study. Joint Bone Spine. 2005;72:567–570.
   PubMed Web of Science ®Google Scholar
• Gupta S, Hawker GA, Laporte A, et al. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with the condition. Rheumatology (Oxford). 2005;44:1531–1537.
   PubMed Web of Science ®Google Scholar
• Li X, Gignac MA, Anis AH. The indirect costs of arthritis resulting from unemployment, reduced performance and occupational changes while at work. Med Care. 2006;44:304–310.
   PubMed Web of Science ®Google Scholar
• Schofield D, Percival R, Passey M, et al. Modelling the cost of ill health in Health and Wealth MOD (Version II): lost labour force participation, income and taxation, and the impact of disease prevention. Int J Microsimulation. 2011;4:32–36.
   Google Scholar
• Tracey I, Bushnell M. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain. 2009;10:1113–1120.
   PubMed Web of Science ®Google Scholar
• Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287–333.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, safe and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017;20:S3–S92.
   PubMed Web of Science ®Google Scholar
• Breivik H, Eisenberg E, O’Brien T, OPEN Minds. The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health. 2013 Dec; 24(13):1229.
   Google Scholar
• Garcia JB. Change pain Latin America Advisory Panel. Change Pain Latin America-new initiative established to enhance management of patients with chronic pain in Latin America. Braz J Anesthesiol. 2014 Mar–Apr;64(2):140–142.
   PubMedGoogle Scholar
• Choiniere M, Dion D, Peng P, et al. The Canadian STOP-PAIN project-Part1: who are the patients on the waitlists of multidisciplinary pain treatment facilities? Can J Anesth. 2010;57:539–548.
   PubMed Web of Science ®Google Scholar
• Fishbain DA, Goldberg M, Rosonoff RS, et al. Completed suicide in chronic pain. Clin J Pain. 1991;7:29–36.
   PubMed Web of Science ®Google Scholar
• Tang N, Crane C. Suicidality in chronic pain: review of the prevalence, risk factors and psychological links. Psychol Med. 2006;36:575–586.
   PubMed Web of Science ®Google Scholar
• Conaghan PG, Peloso PM, Everett SV, et al. Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies. Rheumatology (Oxford). 2015;54(2):270–277.
   PubMed Web of Science ®Google Scholar
• Laires PA, Lains J, Miranda LC, et al. Inadequate pain relief among patients with primary knee osteoarthritis. DOI:10.1016/j.rbre.2016.11.005
   Google Scholar
• Altman R. Pain relief in osteoarthritis: the rationale for combination therapy. J Rheumatol. 2004;31:5–7.
   PubMed Web of Science ®Google Scholar
• Kennedy S, Michael M. Pharmacological treatment of osteoarthritis of the hip and knee. BCMJ. 2010;52:404–409.
   Google Scholar
• Osteoarthritis Research Society International (OARSI). OARSI Primer. [cited 2017 Jul 16]. http://primer.oarsi.org/
   Google Scholar
• Taylor SD, Everett SV, Taylor TN, et al. A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control. Open Access Rheum Res Rev. 2013;5:69–76.
   Google Scholar
• Dekker J, Tola P, Aufdemkampe G, et al. Negative affect, pain and disability in osteoarthritis patients: the mediating role of muscle weakness. Behav Res Ther. 1993;31:203–206.
   PubMed Web of Science ®Google Scholar
• Farr IJ, Miller LE, Block JE. Quality of life in patients with knee osteoarthritis: a commentary on nonsurgical and surgical treatments. Open Orthop J. 2013;13:619–623.
   Google Scholar
• Desmeules F, Dionne CE, Belzile E, et al. Waiting for total knee replacement surgery: factors associated with pain, stiffness, function and quality of life. BMC Musculoskelet Disord. 2009;10:52.
   PubMed Web of Science ®Google Scholar
• Alkan BM, Fidan F, Tosun A, et al. Quality of life and self-reported disability in patients with knee osteoarthritis. Mod Rheumatol. 2014;24:166–171.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Carotti M, Stancati A. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res. 2005;17:255–263.
   PubMed Web of Science ®Google Scholar
• Ayers DC, Franklin PD, Trief PM, et al. Psychological attributes of postoperative total joint replacement patients: implications for optimal physical outcome. J Arthroplasty. 2004;19(7 Suppl2):125–130.
   PubMedGoogle Scholar
• Ayers DC, Franklin PD, Ring DC, et al. The role of emotional health in functional outcomes after orthopaedic surgery: extending the Biopsychosocial model to orthopaedics. J Bone Joint Surg AM. 2013;95(21):e165.
   PubMed Web of Science ®Google Scholar
• Kidd B. Mechanisms of pain in osteoarthritis. HSS J. 2012;8(1):26–28.
   PubMedGoogle Scholar
• Sofat N, Ejindu V, Kiely P. What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology (Oxford). 2011;50(12):2157–2165.
   PubMed Web of Science ®Google Scholar
• Fitzcharles MH, Almahrezi A, Shir Y. Pain: understanding and challenges for the rheumatologist. Arthritis Rheum. 2005;52:3685–3692.
   PubMed Web of Science ®Google Scholar
• Ji RR, Befort K, Brenner GJ, et al. Erk MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci. 2002;22:478–485.
   PubMed Web of Science ®Google Scholar
• Schaible HG. Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep. 2012;14(6):549–556.
   PubMed Web of Science ®Google Scholar
• Felson DT, Chaisson CE, Hill CL. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med. 2001;134:541–549.
   PubMed Web of Science ®Google Scholar
• Taljanovich MS, Graham AR, Benjamin JB, et al. Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination. Radiographic findings, and histopathology. Skeletal Radiol. 2008;37:423–431.
   PubMed Web of Science ®Google Scholar
• Roemer FW, Kassim Javaid M, Guermazi A, et al. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI. Osteoarthritis Cartilage. 2010;18:1269–1274.
   PubMed Web of Science ®Google Scholar
• Baker K, Grainger A, Niu J, et al. Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann Rheum Dis. 2010;69:1779–1783.
   PubMed Web of Science ®Google Scholar
• Baliki MN, Geha PY, Jabakhanji R, et al. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain. 2008;4:47.
   PubMed Web of Science ®Google Scholar
• Kulkarni B, Bentley DE, Elliott R, et al. Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum. 2007;56:1345–1354.
   PubMedGoogle Scholar
• Grady D, Berkowitz SA, Katz MH. Opioids for chronic pain. Arch Intern Med. 2011;171(16):1426.
   PubMed Web of Science ®Google Scholar
• George JM, Menon M, Gupta P, et al. Use of strong opioids for chronic non-cancer pain: a retrospective analysis at a pain centre in Singapore. Singapore Med J. 2013;54(9):506–510.
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GL, Fine PG, et al. The American Pain Society-American Academy of Pain Medicine. Clinical Guidelines for the use of opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130.
   PubMed Web of Science ®Google Scholar
• Chou R, Ballantyne JC, Fanciullo GJ, et al. Research gaps in the use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:147–159.
   PubMed Web of Science ®Google Scholar
• Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1:CD006605.
   PubMed Web of Science ®Google Scholar
• Moisset X, Trouvin AP, Tran VT, et al. Use of strong opioids in chronic non-cancer pain in adults. Evidence-based recommendations from the French Society for the Study and Treatment of Pain. Presse Med. 2016;45(4):447–462.
   PubMed Web of Science ®Google Scholar
• Rico MA, Campos Kraychete D, Jreigelskandar A, et al. Use of opioids in Latin America: the need of an evidence-based change. Pain Med. 2016;17:704–716.
   PubMed Web of Science ®Google Scholar
• Kraychete DV, Siqueira JT, Zakka TR, et al. Specialists group recommendations for the use of opioids in Brazil: part III. Use in special situations (postoperative pain, musculoskeletal pain, neuropathic pain, gestation and lactation). Rev Dor. 2014;15(2):126–132.
   Google Scholar
• Kraychete DC, Sakata RK. Use and rotation of opioids in chronic non-oncologic pain. Rev Bras Anestesiol. 2012;62(4):554–562.
   PubMed Web of Science ®Google Scholar
• Breivik H, Gordh T, Butler S. Keeping an open mind: achieving balance between too liberal and too restrictive prescription of opioids for chronic non-cancer pain: using a two-edged sword. Scand J Pain. 2012;3:1–4.
   Google Scholar
• Hutchinson K, Moreland AM, de Williams ACC, et al. Exploring beliefs and practice of opioids prescribing for persistent non-cancer pain by general practitioners. Eur J Pain. 2007;11:93–98.
   PubMed Web of Science ®Google Scholar
• Spitz A, Moore AA, Papaleontiou M, et al. Primary care provider’s perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study. BMC Geriatr. 2011;11:35.
   PubMed Web of Science ®Google Scholar
• Srivastava A, Kahan M, Jiwa A. Prescription opioid use and misuse: plotting an educational strategy for rural primary care physicians. Can Farm Physician. 2012;58:e210–e216.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. Ensuring availability of controlled medications for the relief of pain and preventing diversions and abuse. Striking the right balance to achieve the optimal public health outcome. Discussion paper based on a scientific work-shop. UNDOC, Vienna, Austria, January 18–19. 2011. Available from: www.undoc.org/docs/treatment/Pain/Ensuring_availability_of_controlled_medications_FINAL_15_March_CND_version.pdf
   Google Scholar
• Weisberg DF, Becker WC, Fiellin DA, et al. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons. Int J Drug Policy. 2014;25:1124–1130.
   PubMed Web of Science ®Google Scholar
• Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician. 2014;17:e119–e128.
   PubMed Web of Science ®Google Scholar
• Islam MM, McRae IS, Masumdar S, et al. Prescription opioid analgesics for pain management in Australia. Twenty years of dispensing. Intern Med J. 2016;46:955–963.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Alturi S, Hansen H, et al. Opioids in chronic non-cancer pain. Have we reached a boiling point yet? Pain Physician. 2014;17:e1–e10.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Kaye AM, Kaye AD. Current state of opioid therapy and abuse. Curr Pain Headache Rep. 2016;20:34.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Ensuring balance in national policies on controlled substances: guidance for availability and accessibility of controlled medicines. Geneva: WHO; 2011.
   Google Scholar
• Single Convention on Narcotic Drugs, 1961. As attended by the 1972 protocol amending the single convention on narcotic drugs, 1962. New York (NY): United Nations; 1977 [cited 2017 Apr 18]. Available from: http://www.unodc.org/pdf/convention_1961_en.pdf
   Google Scholar
• Milani B, Scholten W. Access to controlled medicines in: the world medicines situation 2011. 3rd ed. Geneva: World Health Organization; 2011 Chapter released 2011 Apr. [cited 2017 Apr 18]. Available from: http://www.who.int/entity/medicines/areas/policy/world_medicines_situation/WMS_ch19_wAccess.pdf
   Google Scholar
• Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387:1644–1656.
   PubMed Web of Science ®Google Scholar
• INCB, 2006 International Narcotics Control Board 2005. Report of the International Narcotics Control Board for 2005 (E/INCB/2005/1). New York: United Nations; 2006 [cited 2017 Apr 18]. Available from: www.ntakd.it/en/files/INCB2005(en).pdf
   Google Scholar
• Hernández JJ, Moreno C. Dolor el quinto signo vital. (Pain the fifth vital sign). In: Hernández JJ, Moreno C, editors. Medicina del dolor. 2nd ed. Bogotá: Ediciones Rosaristas; 2011. p. 19–40.
   Google Scholar
• Gupta A, Weber N, Duwell M. Implementing a public health approach for the management of chronic pain in the USA. Pain Manag. 2013;3(4):315–319.
   PubMedGoogle Scholar
• Hahn K. Strategies to prevent opioid misuse, abuse and diversion that may also reduce the associated costs. Am Health Drug Benefits. 2011;4(2):107–114.
   PubMedGoogle Scholar
• Gourlay D, Heit H. Universal precautions: a matter of mutual trust and responsibility. Pain Med. 2006;7:210–211.
   PubMed Web of Science ®Google Scholar
• Wang J, Christo PJ. The influence of prescription monitoring programs on chronic pain management. Pain Physician. 2009;12:507515.
   Web of Science ®Google Scholar
• US Drug Enforcement Administration. Electronic prescriptions for controlled substances. Docket No. DEA-218I; RIN 1117-AA61. Federal Register. 2010;75:16236–16319.
   Google Scholar
• Lohr M. House Bill No. 964. Commonwealth of Virginia General Assembly; Feb 2010 18. [cited 2017 Apr 19]. http://leg1.state.va.us/cgi-bin/legp504.exe?101+ful+HB964H1
   Google Scholar
• Pharmacy Voice. FDA: reformulated Oxycontin may be less prone to abuse. Apr 7 2010 [cited 2017 Apr 19]. Available from: http://nacds.rxpost.net/News/article.cfm?Article_ID=561428
   Google Scholar
• Uso de opioides en tratamiento de dolor (use of opioids in the treatment of pain) Manual para Latinoamérica. La Asociación Latinoamericana de Cuidados Paliativos. [cited 2017 Jul 16]. Available from: http://cuidadospaliativos.org/uploads/2012/11/ManualOpioides.pdf
   Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22:363–388.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64:465–474.
   PubMed Web of Science ®Google Scholar
• Cibulka MT, White DM, Woehrle J, et al. Hip pain and mobility deficits—hip osteoarthritis: clinical practice guidelines linked to the international classification of functioning, disability, and health from the orthopaedic section of the American Physical Therapy Association. J Orthop Sports Phys Ther. 2009;39:A1–25.
   PubMed Web of Science ®Google Scholar
• Herndon CM, Hutchison RW, Berdine HJ, et al. Management of chronic nonmalignant pain with nonsteroidal anti-inflammatory drugs. Joint opinion statement of the ambulatory care, cardiology, and pain and palliative care practice and research networks of the American College of Clinical Pharmacy. Pharmacotherapy. 2008;28:788–805.
   PubMed Web of Science ®Google Scholar
• MQIC. Medical management of adults with osteoarthritis. In Southfield (MI): Michigan Quality Improvement Consortium; 2011. 1.
   Google Scholar
• American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee. 2nd ed. Rosemont (IL): American Academy of Orthopaedic Surgeons; 2013.
   Google Scholar
• Loew L, Brosseau L, Wells GA, et al. Ottawa panel evidence-based clinical practice guidelines for aerobic walking programs in the management of osteoarthritis. Arch Phys Med Rehabil. 2012;93:1269–1285.
   PubMed Web of Science ®Google Scholar
• Roddy E, Zhang W, Doherty M, et al. Evidence based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee—the MOVE consensus. Rheumatology (Oxford). 2005;44:67–73.
   PubMed Web of Science ®Google Scholar
• The National Collaborating Centre for Chronic Conditions. Osteoarthritis: national clinical guideline for care and management in adults. London (UK): Royal College of Physicians; 2008. p. 319.
   Google Scholar
• Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:377–388.
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64:669–681.
   PubMed Web of Science ®Google Scholar
• Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145–1155.
   PubMed Web of Science ®Google Scholar
• Peter WF, Jansen MJ, Hurkmans EJ, et al. Physiotherapy in hip and knee osteoarthritis: development of a practice A.E. Nelson et al./Seminars in Arthritis and Rheumatism 43 (2014) 701–712 711 guideline concerning initial assessment, treatment and evaluation. Acta Reumatol Port. 2011;36:268–281.
   PubMed Web of Science ®Google Scholar
• Gelis A, Coudeyre E, Hudry C, et al. Is there an evidence-based efficacy for the use of foot orthotics in knee and hip osteoarthritis? Elaboration of French clinical practice guidelines. Joint Bone Spine. 2008;75:714–720.
   PubMed Web of Science ®Google Scholar
• Mazieres B, Thevenon A, Coudeyre E, et al. Adherence to, and results of, physical therapy programs in patients with hip or knee osteoarthritis. Development of French clinical practice guidelines. Joint Bone Spine. 2008;75:589–596.
   PubMed Web of Science ®Google Scholar
• Pongparadee C, Penserga E, Lee DJ, et al. Current considerations for the management of musculoskeletal pain in Asian countries: a special focus on cyclooxygenase-2 inhibitors and non-steroid anti-inflammation drugs. Int J Rheum Dis. 2012;15:341–347.
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137–162.
   PubMed Web of Science ®Google Scholar
• Schnitzer TJ, Ekman EF, Sierings EI, et al. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain. Ann Rheum Dis. 2015;74:1202–1211.
   PubMed Web of Science ®Google Scholar
• Laudy AB, Bakker EW, Rekers M, et al. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2015;49:657–672.
   PubMed Web of Science ®Google Scholar
• Nüesch E, Rutjes AW, Husni E, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev. 2009;(4):CD003115.
   PubMed Web of Science ®Google Scholar
• Schaefert R, Welsch P, Klose P, et al. Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration. Schmerz. 2015;29(1):47–59.
   PubMed Web of Science ®Google Scholar
• Rauck R, Rapoport R, Thipphawong J. Results of a double-blind, placebo-controlled, fixed-dose assessment of once-daily OROS® hydromorphone ER in patients with moderate to severe pain associated with chronic osteoarthritis. Pain Pract. 2013;13(1):18–29.
   PubMed Web of Science ®Google Scholar
• Burgos-Vargas R, Cardiel M, Loyola-Sánchez A, et al. Characterization of knee osteoarthritis in Latin America. A comparative analysis of clinical and health care utilization in Argentina, Brazil and Mexico. Rheumatol Clin. 2014;10(3):152–159.
   Google Scholar
• Haq SA, Davatchi F. Osteoarthritis of the knees in the COPCORD world. Int J Rheum Dis. 2011;14:122–129.
   PubMed Web of Science ®Google Scholar
• National Opioid Use Guideline Group. Canadian guidelines for safe and effective use of opioids for chronic non-cancer pain. Hamilton: NOUGG; 2010. Available from: http://nationalpaincentre.mcmaster.ca/opioid/
   Google Scholar
• Tornero-Molina JJ, Vidal Fuentes J, Alonso-Ruiz A, et al. Documento de consenso de la Sociedad Española de Rheumatología para el uso de opioides en el tratamiento de dolor reumático. (Consensus document of the Spanish Society of Rheumatology for the use of opioids in the treatment of rheumatic pain). Rheumatol Clin. 2006;2(S1):S50–54.
   Google Scholar
• Benyamin R, Trescot A, Datta S, et al. Opioid complication and side effects. Pain Physician. 2008; opioid special issue;11:S105–S120.
   PubMed Web of Science ®Google Scholar
• Lara-Solares A, Zamora CA, Garcia CA, et al. Latin-American guidelines for opioid use in chronic nononcologic pain. Pain Manag. 2017. DOI:10.2217/pmt-2016-0065
   Web of Science ®Google Scholar
• Moore AR, McQuay HJ. Prevalence of opioid adverse effects in chronic non-malignant pain: systematic review of randomized trials of oral opioids. Arthritis Res Ther. 2005;7:R1046–R1051.
   PubMed Web of Science ®Google Scholar
• Johnsson T, Christrup LL, Hojsted J, et al. Symptoms and side effects in chronic non-cancer pain: patient report vs systematic assessment. Acta Anaesthesiol Scand. 2010;55:69–74.
   PubMed Web of Science ®Google Scholar
• Tamayo A, Diaz-Zuluaga P. Opioid-induced bowel dysfunction. AAHPC Bulletin. 2007;8:6–7.
   Google Scholar
• Gupta S, Atcheson R. Opioid and chronic non-cancer pain. J Anaesthesiol Clin Pharmacol. 2013;29(1):6–12.
   PubMedGoogle Scholar
• Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747–758.
   PubMed Web of Science ®Google Scholar
• McNicol E, Horowicz_Mehler N, Fisk R, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4(5):231–256.
   PubMed Web of Science ®Google Scholar
• Vella Brincat J. Adverse effects of opioids on central nervous system of palliative care patients. J Pain Palliat Care Pharmacother. 2007;21:15–25.
   PubMedGoogle Scholar
• Ray WA, Chung CP, Murray KT, et al. Prescription of long-acting opioids and mortality in patients with chronic non-cancer pain. Jama. 2016;315:2415–2423.
   PubMed Web of Science ®Google Scholar
• Chau DL, Walker V, Pai L, et al. Opiates and elderly: use and side effects. Clin Interv Aging. 2008;3(2):273–278.
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Marsch LA, Joseph H, et al. Opioids and the treatment of chronic pain: controversies, current status and future directions. Exp Clin Psychopharmacol. 2008;16(5):405–416.
   PubMed Web of Science ®Google Scholar
• Breivik H, Ljosaa TM, Stengaard-Pedersen K, et al. A 6-months, randomized, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids. Scand J Pain. 2010;1(3):122–141.
   Google Scholar
• Plosker GL. Buprenorphine 5, 10 and 20 μg/h transdermal patch. Drugs. 2011;71(18):2491–2509.
   PubMedGoogle Scholar
• Volkow ND, Thomas McLellan A. Opioid abuse in chronic pain-Misconceptions and mitigation strategies. N Engl J Med. 2016;374:1253–1263.
   PubMed Web of Science ®Google Scholar
• Butler SF, Black RA, Cassidy TA, et al. Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduct J. 2011;8:29.
   PubMed Web of Science ®Google Scholar
• Williams JT, Christie MI, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 2001;81:299–343.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Morales M. The brain on drugs: from reward to addiction. Cell. 2015;162:712–725.
   PubMed Web of Science ®Google Scholar
• Results from the 2013 National Survey on Drug Use and Health: summary of national findings. NSDUH series H-48. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2014. HHS publication no. (SMA)14-4863.
   Google Scholar
• Shei A, Rice JB, Kirson NY, et al. Sources of prescription opioids among diagnosed opioid abusers. Curr Med Res Opin. 2015;31:779–784.
   PubMed Web of Science ®Google Scholar
• Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15:ES67–ES92.
   PubMed Web of Science ®Google Scholar
• O’Brien C. Managing patients with a history of substance abuse. Can Fam Physician. 2014;60:248–250.
   PubMed Web of Science ®Google Scholar